14-3-3s Are Potential Biomarkers for HIV-related Neurodegeneration

Overview

Journal J Neurovirol

Publisher Springer

Specialties Microbiology
Neurology

Date 2012 Jul 20

PMID 22811265

Citations 12

Authors

Diana Morales

Efthimios C M Skoulakis

Summer F Acevedo

Affiliations

Soon will be listed here.

Abstract

Over the last decade, it has become evident that 14-3-3 proteins are essential for primary cell functions. These proteins are abundant throughout the body, including the central nervous system and interact with other proteins in both cell cycle and apoptotic pathways. Examination of cerebral spinal fluid in humans suggests that 14-3-3s including 14-3-3ε (YWHAE) are up-regulated in several neurological diseases, and loss or duplication of the YWHAE gene leads to Miller-Dieker syndrome. The goal of this review is to examine the utility of 14-3-3s as a marker of human immune deficiency virus (HIV)-dependent neurodegeneration and also as a tool to track disease progression. To that end, we describe mechanisms implicating 14-3-3s in neurological diseases and summarize evidence of its interactions with HIV accessory and co-receptor proteins.

Citing Articles

Patterns of autoantibody expression in multiple sclerosis identified through development of an autoantigen discovery technology.

DiCillo E, Kountikov E, Zhu M, Lanker S, Harlow D, Piette E J Clin Invest. 2025; 135(5).

PMID: 40026247 PMC: 11870742. DOI: 10.1172/JCI171948.

14-3-3 proteins-a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer's disease.

Abdi G, Jain M, Patil N, Upadhyay B, Vyas N, Dwivedi M Front Mol Biosci. 2024; 11:1286536.

PMID: 38375509 PMC: 10876095. DOI: 10.3389/fmolb.2024.1286536.

Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise.

Giloteaux L, Glass K, Germain A, Franconi C, Zhang S, Hanson M J Extracell Vesicles. 2024; 13(1):e12403.

PMID: 38173127 PMC: 10764978. DOI: 10.1002/jev2.12403.

The 14-3-3 Protein Family and Schizophrenia.

Navarrete M, Zhou Y Front Mol Neurosci. 2022; 15:857495.

PMID: 35359567 PMC: 8964262. DOI: 10.3389/fnmol.2022.857495.

Integrated Proteomics Based on 2D Gel Electrophoresis and Mass Spectrometry with Validations: Identification of a Biomarker Compendium for Oral Submucous Fibrosis-An Indian Study.

Venugopal D, Ravindran S, Shyamsundar V, Sankarapandian S, Krishnamurthy A, Sivagnanam A J Pers Med. 2022; 12(2).

PMID: 35207696 PMC: 8878868. DOI: 10.3390/jpm12020208.

References

Wiltfang J, Otto M, Baxter H, Bodemer M, Steinacker P, Bahn E . Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem. 1999; 73(6):2485-90. DOI: 10.1046/j.1471-4159.1999.0732485.x. View

Green A, Thompson E, Stewart G, Zeidler M, McKenzie J, MacLeod M . Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001; 70(6):744-8. PMC: 1737395. DOI: 10.1136/jnnp.70.6.744. View

Datta S, Katsov A, Hu L, Petros A, Fesik S, Yaffe M . 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell. 2000; 6(1):41-51. View

Nakamura H, Aoki H, Hino O, Moriyama M . HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt. Hepatol Res. 2011; 41(5):455-62. DOI: 10.1111/j.1872-034X.2011.00792.x. View

Berg D, Riess O, Bornemann A . Specification of 14-3-3 proteins in Lewy bodies. Ann Neurol. 2003; 54(1):135. DOI: 10.1002/ana.10621. View

Wang W, Shakes D . Molecular evolution of the 14-3-3 protein family. J Mol Evol. 1996; 43(4):384-98. DOI: 10.1007/BF02339012. View

Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P . Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2002; 58(2):192-7. DOI: 10.1212/wnl.58.2.192. View

Vanguilder H, Farley J, Yan H, Van Kirk C, Mitschelen M, Sonntag W . Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline. Neurobiol Dis. 2011; 43(1):201-12. PMC: 3096728. DOI: 10.1016/j.nbd.2011.03.012. View

Poser S, Mollenhauer B, Kraubeta A, Zerr I, Steinhoff B, Schroeter A . How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain. 1999; 122 ( Pt 12):2345-51. DOI: 10.1093/brain/122.12.2345. View

10.

Dube M, Bego M, Paquay C, Cohen E . Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology. 2010; 7:114. PMC: 3022690. DOI: 10.1186/1742-4690-7-114. View

11.

Ushijima H, Nishio O, Klocking R, Perovic S, Muller W . Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur J Neurosci. 1995; 7(6):1353-9. DOI: 10.1111/j.1460-9568.1995.tb01126.x. View

12.

Malim M, Emerman M . HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe. 2008; 3(6):388-98. DOI: 10.1016/j.chom.2008.04.008. View

13.

Bertrand A, Brandel J, Grignon Y, Sazdovitch V, Seilhean D, Faucheux B . Wernicke encephalopathy and Creutzfeldt-Jakob disease. J Neurol. 2009; 256(6):904-9. DOI: 10.1007/s00415-009-5038-1. View

14.

Mignon-Ravix C, Cacciagli P, El-Waly B, Moncla A, Milh M, Girard N . Deletion of YWHAE in a patient with periventricular heterotopias and pronounced corpus callosum hypoplasia. J Med Genet. 2009; 47(2):132-6. DOI: 10.1136/jmg.2009.069112. View

15.

Kapasi A, Fan S, Singhal P . Role of 14-3-3epsilon, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation. Am J Physiol Renal Physiol. 2001; 280(2):F333-42. DOI: 10.1152/ajprenal.2001.280.2.F333. View

16.

Smith B, Krushelnycky B, Mochly-Rosen D, Berg P . The HIV nef protein associates with protein kinase C theta. J Biol Chem. 1996; 271(28):16753-7. DOI: 10.1074/jbc.271.28.16753. View

17.

Goh W, Rogel M, Kinsey C, Michael S, Fultz P, Nowak M . HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med. 1998; 4(1):65-71. DOI: 10.1038/nm0198-065. View

18.

Wang J, Gong C, Zaidi T, Grundke-Iqbal I, Iqbal K . Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem. 1995; 270(9):4854-60. DOI: 10.1074/jbc.270.9.4854. View

19.

Yano M, Nakamuta S, Shiota M, Endo H, Kido H . Gatekeeper role of 14-3-3tau protein in HIV-1 gp120-mediated apoptosis of human endothelial cells by inactivation of Bad. AIDS. 2007; 21(8):911-20. DOI: 10.1097/QAD.0b013e32810539f3. View

20.

Valcour V, Sithinamsuwan P, Letendre S, Ances B . Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep. 2010; 8(1):54-61. PMC: 3035797. DOI: 10.1007/s11904-010-0070-4. View